Pharmaceutical Executive: Thriving ‘Beyond the Pill’: Closing Key Gap in Patient Support

Features
Written By Millie Arora

By Millie P. Arora & Tamara Moellenberg

Why pharma needs to focus on improving—not just extending life.

The future of healthcare should emphasize longevity and quality of life equally, actively supporting both patients and caregivers through the years of living with chronic diseases. In an increasingly competitive market of “miracle treatments” that promise to extend lives, we see an increasing need for services that move beyond the realm of surviving, making “thriving” a key differentiator.

Read the full article on Pharmaceutical Executive.

Millie Arora

As Managing Partner of ReD Associates, Millie oversees the strategic direction of the firm globally. She also drives ReD’s practice in financial services, insurance, and healthcare in the US.

Millie specializes in bringing a social science lens to complex regulatory and B2B situations. In healthcare, she has helped life sciences company build patient-centric agenda including value propositions and patient support programs. In financial services and insurance, she guides her clients towards a better understanding of how people’s complex relationship to money can inform the right way to engage with consumers — both digitally and in-person.

Prior to becoming partner, Millie was the COO of ReD Associates, with a particular focus on company growth. Before joining ReD, Millie was a strategy consultant at the New York Economic Development Corporation under the Bloomberg Administration where she developed a portfolio of initiatives to strengthen the resilience of New York City’s economy following the 2008 financial crisis. She holds a Masters in Public Affairs from Princeton University.

Previous

Alliance Magazine: On the journey to equitable philanthropy
Next

Bloomberg: Going Out? Make It an Event